Prescription drug · ANDA
Isoniazid NDC 71335-3083
Isoniazid 100 mg/1 · Tablet · Oral · Bryant Ranch Prepack
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 71335-3083-1 | 71335308301 | 30 TABLET in 1 BOTTLE (71335-3083-1)Marketed from Feb 16, 2026 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Isoniazid
- Generic name (nonproprietary)
- isoniazid
- Active ingredients
- Isoniazid — 100 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Bryant Ranch Prepack
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 080936
- Marketing start
- Marketing end
- Identifiers
- Product ID 71335-3083_8a54747c-67c0-42c9-bc36-bea05101c811SPL ID 8a54747c-67c0-42c9-bc36-bea05101c811SPL set ID 03bf3bd5-64f9-4491-89fd-96c5c10d0129RxCUI 311166UNII V83O1VOZ8L
- Pharmacologic class
- Antimycobacterial
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N471335308301followed by a unit qualifier and the quantityPackage 71335-3083-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
INDICATIONS AND USAGE Isoniazid tablets, USP are recommended for all forms of tuberculosis in which organisms are susceptible. However, active tuberculosis must be treated with multiple concomitant anti-tuberculosis medications to prevent the emergence of drug resistance. Single-drug treatment of active tuberculosis with isoniazid or any other medication, is inadequate therapy. Isoniazid tablets, USP are recommended as preventive therapy for the following groups, regardless of age. (Note: the criterion for a positive reaction to a skin test (in millimeters of induration) for each group is given in parenthesis): Persons with human immunodeficiency virus (HIV) infection (greater than or equal …
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 080936
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Isoniazid | Isoniazid 100 mg/1 | TabletOral | Teva Pharmaceuticals USA, Inc. | 0555-0066 |
| Isoniazid | Isoniazid 100 mg/1 | TabletOral | Genus Lifesciences | 64950-216 |
| Isoniazid | Isoniazid 100 mg/1 | TabletOral | A-S Medication Solutions | 50090-0410 |